Edward G. Bridges

1.2k total citations
25 papers, 918 citations indexed

About

Edward G. Bridges is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Edward G. Bridges has authored 25 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Edward G. Bridges's work include HIV/AIDS drug development and treatment (11 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (8 papers). Edward G. Bridges is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (8 papers). Edward G. Bridges collaborates with scholars based in United States, France and Italy. Edward G. Bridges's co-authors include Jean‐Pierre Sommadossi, Yung‐Chi Cheng, Claire Pierra, Gilles Gosselin, Kristie Grove Bridges, Andrea M Nazar, Erika Cretton-Scott, Ginger E. Dutschman, Abdesslem Faraj and Zaoli Jiang and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Edward G. Bridges

25 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward G. Bridges United States	16	413	378	315	278	147	25	918
Shigeki Murakami Japan	16	95 0.2×	642 1.7×	828 2.6×	227 0.8×	47 0.3×	51	1.5k
Keith Nieforth United States	16	214 0.5×	249 0.7×	97 0.3×	137 0.5×	120 0.8×	31	792
Paul Meyvisch Belgium	12	1.0k 2.5×	871 2.3×	234 0.7×	278 1.0×	44 0.3×	30	1.6k
Isabelle Lefèbvre France	18	519 1.3×	183 0.5×	33 0.1×	699 2.5×	203 1.4×	47	1.2k
R. H. Decker United States	16	127 0.3×	599 1.6×	612 1.9×	116 0.4×	40 0.3×	28	922
Christina Gavegnano United States	17	472 1.1×	173 0.5×	58 0.2×	183 0.7×	500 3.4×	32	975
Peter Sklar United States	24	1.8k 4.3×	412 1.1×	216 0.7×	221 0.8×	1.4k 9.6×	46	2.2k
Anna Sinistro Italy	12	101 0.2×	146 0.4×	91 0.3×	72 0.3×	53 0.4×	15	875
Geneviève Laflamme United States	14	336 0.8×	105 0.3×	28 0.1×	230 0.8×	117 0.8×	18	583
Gregory E. Chittick United States	15	484 1.2×	198 0.5×	34 0.1×	78 0.3×	287 2.0×	18	798

Countries citing papers authored by Edward G. Bridges

Since Specialization

Citations

This map shows the geographic impact of Edward G. Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward G. Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward G. Bridges more than expected).

Fields of papers citing papers by Edward G. Bridges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward G. Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward G. Bridges. The network helps show where Edward G. Bridges may publish in the future.

Co-authorship network of co-authors of Edward G. Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Edward G. Bridges. A scholar is included among the top collaborators of Edward G. Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward G. Bridges. Edward G. Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heer, Ellen C. de, Christos E. Zois, Edward G. Bridges, et al.. (2023). Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 143–143. 9 indexed citations

Fallon, Nina, et al.. (2017). Development of an Educational Activity for First- and Second-Year Medical Students Using Cadaver Pathologies to Enhance Clinical Reasoning and Prepare for Entrustment in Providing Oral Case Presentations. Medical Science Educator. 27(2). 391–399. 3 indexed citations

Bridges, Edward G., et al.. (2012). Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetology & Metabolic Syndrome. 4(1). 14–14. 108 indexed citations

Bridges, Edward G., J.R. Selden, & Shouqi Luo. (2008). Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis B. Antimicrobial Agents and Chemotherapy. 52(7). 2521–2528. 23 indexed citations

Pierra, Claire, Agnès Amador, S. Benzaria, et al.. (2006). Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-C-Methylcytidine. Journal of Medicinal Chemistry. 49(22). 6614–6620. 147 indexed citations

Pierra, Claire, S. Benzaria, David Dukhan, et al.. (2004). Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent. Antiviral chemistry & chemotherapy. 15(5). 269–279. 3 indexed citations

Benzaria, S., Claire Pierra, Dorothée Bardiot, et al.. (2003). Monoval-LdC: Efficient Prodrug of 2′-Deoxy-β-L-cytidine (L-dC), A Potent and Selective Anti-HBV Agent. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1003–1006. 3 indexed citations

Standring, David N., Robert E. Lanford, Teresa L. Wright, et al.. (2003). NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee. Journal of Hepatology. 38. 3–3. 15 indexed citations

Hernández-Santiago, Brenda I., L Placidi, Achraf Al Faraj, et al.. (2002). Pharmacology of β- l -Thymidine and β- l -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 46(6). 1728–1733. 43 indexed citations

10.

Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations

11.

Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). Antiviral l -Nucleosides Specific for Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 45(1). 229–235. 144 indexed citations

12.

Bridges, Edward G., Zaoli Jiang, & Yung‐Chi Cheng. (1999). Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria. Journal of Biological Chemistry. 274(8). 4620–4625. 61 indexed citations

13.

Dutschman, Ginger E., Edward G. Bridges, Shwu-Huey Liu, et al.. (1998). Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β- l (−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus β- d (+) Nucleoside Analogs In Vitro. Antimicrobial Agents and Chemotherapy. 42(7). 1799–1804. 40 indexed citations

14.

Bridges, Edward G., Ginger E. Dutschman, Elizabeth A. Gullen, & Yung‐Chi Cheng. (1996). Favorable interaction of β-l(−) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus. Biochemical Pharmacology. 51(6). 731–736. 29 indexed citations

15.

Bridges, Edward G., et al.. (1996). 3‘‐Azido‐ 3’‐deoxythymidine inhibits erythroid‐specific transcription factors in human erythroid K562 leukemia cells. European Journal Of Haematology. 56(1-2). 62–67. 7 indexed citations

16.

Bridges, Edward G. & Yang Cheng. (1995). Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.. PubMed. 13. 231–45. 15 indexed citations

17.

Bridges, Edward G., Abdesslem Faraj, & Jean‐Pierre Sommadossi. (1993). Inhibition of mammalian dna polymerase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine. Biochemical Pharmacology. 45(8). 1571–1576. 32 indexed citations

18.

Bridges, Edward G., et al.. (1993). Influence of template primary structure on 3′-azido-3′-deoxythymidine triphosphate incorporation into DNA. Antiviral Research. 21(2). 93–102. 4 indexed citations

19.

Weidner, Douglas A., Edward G. Bridges, E M Cretton, & Jean‐Pierre Sommadossi. (1992). Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.. Molecular Pharmacology. 41(2). 252–258. 23 indexed citations

20.

Bridges, Edward G.. (1954). THE REFORMS OF 1854 IN RETROSPECT. The Political Quarterly. 25(4). 316–323. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact